Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
09/15/2011 | WO2011112089A2 Mutated rep encoding sequences for use in aav production |
09/15/2011 | WO2011110073A1 Isolation and purification method of cell culture mixture |
09/15/2011 | WO2011057248A3 Methods of propagating monkey adenoviral vectors |
09/15/2011 | US20110223199 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
09/15/2011 | US20110223135 SIMIAN ADENOVIRUSES SAdV-43, -45, -46, -47, -48, -49, AND -50 AND USES THEREOF |
09/14/2011 | EP2365082A1 BVDV virus-like particles |
09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
09/14/2011 | CN102181461A Method for expressing target polypeptide on filobactivirus at high density and application thereof |
09/14/2011 | CN102181408A Preparation method and application of Saint Louis encephalitis virus-like particles |
09/14/2011 | CN102181407A Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell |
09/14/2011 | CN102181406A Recombinant adenovirus, dendritic cell (DC) modified by recombinant adenovirus and application of recombinant adenovirus and DC |
09/14/2011 | CN102181405A Recombinant virus and method for producing L-asparaginase II by using virus |
09/14/2011 | CN102181404A Recombinant adenovirus expressing E0, E2 gene of classical swine fever virus |
09/14/2011 | CN102181403A Research on technology for artificially modifying extended-spectrum bacteriophage |
09/14/2011 | CN102181399A Mouse liver tumor cell line for highly expressing CD133 and preparation method thereof |
09/14/2011 | CN102180951A Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof |
09/14/2011 | CN102178948A Genetic engineering drug for treating and/or preventing cervical cancer |
09/14/2011 | CN102178947A Live vector vaccine for expressing peste des petits ruminants virus (PPRV) H gene and preparation method thereof |
09/14/2011 | CN102178946A Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production |
09/14/2011 | CN101186637B Method for inhibiting influenza virus infection and medicament thereof |
09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
09/13/2011 | US8017154 Polyamino acid for use as adjuvant |
09/13/2011 | US8017127 Influenza immunogen and vaccine |
09/13/2011 | CA2329060C Aav5 vector and uses thereof |
09/13/2011 | CA2220964C Alphavirus rna replicon systems |
09/09/2011 | WO2011107534A1 Recombinant attenuated parvovirus |
09/09/2011 | WO2011107439A1 A method for measuring viral infectivity |
09/09/2011 | CA2790653A1 Recombinant attenuated parvovirus |
09/08/2011 | US20110219464 Lung disease targets and uses thereof |
09/08/2011 | US20110217772 Animal protein free media for cultivation of cells |
09/08/2011 | US20110217757 Modified vaccinia ankara virus variant and cultivation method |
09/08/2011 | US20110217756 Newly isolated bacteriophage specific to klebsiella pneumoniae |
09/08/2011 | US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
09/08/2011 | US20110217693 Generation of Replication Competent Viruses for Therapeutic Use |
09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
09/08/2011 | US20110217330 Novel method |
09/08/2011 | US20110217267 Gene therapy vectors and cytosine deaminases |
09/08/2011 | US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof |
09/07/2011 | EP2363493A1 Novel insertion sites in pox vectors |
09/07/2011 | EP2363464A1 DNA modular cloning vector plasmids and methods for their use |
09/07/2011 | EP2363462A1 Novel baculoviral vector |
09/07/2011 | EP2362901A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents |
09/07/2011 | CN1840204B Lentiviral vectors for the preparation of immunotherapeutical compositions |
09/07/2011 | CN102177233A Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
09/07/2011 | CN102174508A Method for screening non-essential regions for replication of goat pox virus and universal transfer vectors for same |
09/07/2011 | CN102174482A Method for separating and purifying phycophage from blue algae outbreak water body |
09/07/2011 | CN102174481A Cotton leafworm genetically engineered virus I and construction method thereof |
09/07/2011 | CN102174480A Prodenia litura genetically engineered virus NO.2 and construction method thereof |
09/07/2011 | CN102174479A Oncolytic virus for targeted treatment of human tumors and application thereof |
09/07/2011 | CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy |
09/07/2011 | CN102174477A Hepatitis A virus strain SH and diploid cell adaptation method thereof |
09/07/2011 | CN102174476A Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof |
09/07/2011 | CN102174473A K562-PM-RFP cell strain |
09/07/2011 | CN102174468A Method and application for inducing human umbilical cord mesenchyme stem cells to be differentiated into testicular interstitial cells |
09/07/2011 | CN102174466A Porcine somatic cell mutagensis method |
09/07/2011 | CN102174444A Method for proliferating H9 subtype avian influenza virus and pasteurella by chick embryos |
09/06/2011 | US8012749 Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells |
09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
09/06/2011 | US8012738 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
09/06/2011 | US8012737 Methods of producing influenza vaccine compositions |
09/06/2011 | US8012736 Multi plasmid system for the production of influenza virus |
09/06/2011 | US8012735 Infectious cDNA clone of the modified live virus vaccine strain of Equine arteritis virus |
09/06/2011 | CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
09/01/2011 | WO2011106743A1 Recombinant cdv compositions and uses thereof |
09/01/2011 | WO2011070440A3 Oncolytic rhabdovirus |
09/01/2011 | US20110212986 Anti-flavivirus therapeutic |
09/01/2011 | US20110212859 Radio frequency identifiers for use in biological science |
09/01/2011 | US20110212493 Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products |
09/01/2011 | US20110212488 Immortalized avian cell lines and use thereof |
09/01/2011 | US20110212434 Novel hiv-based recombinant viral clones and use thereof in analytical methods |
09/01/2011 | US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions |
09/01/2011 | US20110212130 Live, attenuated respiratory syncytial virus |
09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
09/01/2011 | US20110212085 Lung cancer disease targets and uses thereof |
09/01/2011 | US20110212056 Combination therapy for the treatment of liver diseases |
09/01/2011 | CA2791787A1 Recombinant cdv compositions and uses thereof |
08/31/2011 | EP2361975A1 Method for influenza virus purification |
08/31/2011 | EP2361974A1 Use of proteins and peptides encoded by the genome of a new coronavirus strain associated with SARS |
08/31/2011 | EP2361304A2 Novel method |
08/31/2011 | CN1833024B Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto |
08/31/2011 | CN102171334A Method for producing purified influenza virus antigen |
08/31/2011 | CN102168075A Recombinant adenovirus carrying rat retinoic acid receptor (RAR) gamma gene and construction method thereof |
08/31/2011 | CN102168074A Recombinant adenovirus and application thereof |
08/31/2011 | CN102168073A Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production |
08/31/2011 | CN102168070A Human laryngeal epithelium cancer cell as well as preparation method and application thereof |
08/31/2011 | CN102166228A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
08/31/2011 | CN102165901A Method for preventing and treating Pseudomonas solanacearum |
08/30/2011 | US8008460 Polynucleotide fragments of an infectious human endogenous retrovirus |
08/30/2011 | US8008000 Viral variants detection and application |
08/30/2011 | US8007817 Compositions and methods for treating microbial infections |
08/30/2011 | US8007792 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
08/30/2011 | CA2491872C Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
08/30/2011 | CA2405458C Herpes viruses for immune modulation |
08/25/2011 | WO2011103185A1 Human group p immunodeficiency virus and uses thereof |
08/25/2011 | WO2011103137A1 Cell-based methods and reagents |
08/25/2011 | WO2011080505A3 Method of growing phage for commercial use |
08/25/2011 | US20110209228 Method of treatment using antimicrobial composition |
08/25/2011 | US20110207223 Methods of generating alphavirus particles |
08/25/2011 | US20110207202 Method for the production of adenoviral vectors |